STAT+: For unlucky mountaineers, tundra explorers, and the unhoused, a new drug could avert the ravages of frostbite
The FDA's approval of Aurlumyn (ilosprost) culminates decades of research that has slowly and quietly transformed treatment for the disabling and notoriously hard-to-study disease.
Two days after his right hand froze, Hart Bezner realized for the first time that he might lose it.
The retired physics professor was sitting in an emergency room in Whitehorse, the capital of Canada’s Yukon territory, where two doctors and a pharmacist were taking an unusual amount of interest in the appendage and the pink blisters that now covered it.
“Will I lose my hand?” he remembers asking. “Will this go away?”
What's Your Reaction?
